Roche signs Alzheimer’s deal with reMYND
September 7, 2010Research and Development Alzheimer's, Parkinson's, Roche, reMYND
Roche has signed a deal with Belgian biotech reMYND to develop new treatments for patients with Alzheimer’s and Parkinson’s disease. …
Merck averts day in court over Dutch plant closure
September 7, 2010Manufacturing and Production, Research and Development Merck & Co, Netherlands, job cuts
Merck & Co has postponed the planned closure of the former Organon facility in Oss, the Netherlands, after weeks of …
FDA cites another Sun Pharma unit for GMP violations
September 7, 2010Manufacturing and Production Sun Pharma, manufacturing compliance
Sun Pharmaceuticals’ manufacturing operations have been found wanting by FDA for the second time in recent months, once again for …
Pharma manufacturing news in brief
September 7, 2010Manufacturing and Production Aegis Protek, Alexion, Halozyme, Ranbaxy, SemBioSys
A round-up of pharma manufacturing developments from Ranbaxy, SemBioSys, Halozyme, Aegis Protek, Alexion and Thomson/Rondaxe. Ranbaxy Laboratories of India has …
Stephen Stamp joins board at Eusa Pharma
September 7, 2010Sales and Marketing Eusa Pharma, appointment, sales and marketing
Transatlantic specialty company Eusa Pharma has appointed Stephen Stamp to its board as an independent non-executive director. Stephen has previously …
Russian API manufacturer eyes IPO and acquisitions
September 7, 2010Manufacturing and Production API, Pharmsynthez, Russia
Russian active pharmaceutical ingredient manufacturer Pharmsynthez is planning a listing on the MICEX stock exchange to help it expand beyond …
New form of Levitra wins EU approval
September 7, 2010Sales and Marketing Bayer, Levitra, erectile dysfunction
Bayer is to launch a new formulation of its erectile dysfunction drug Levitra. The European Commission granted Levitra (verdenafil HCI) …
Pressure mounts on GSK over Avandia
September 6, 2010Sales and Marketing Avandia, GlaxoSmithKline
GlaxoSmithKline is under mounting pressure this week as calls intensify for its type II diabetes drug Avandia to be withdrawn …
Parallel trading restricting medicine access, says ABPI
September 6, 2010Sales and Marketing parallel trade, pharmacists, supply chain
The ABPI has blamed parallel trading by a minority of pharmacists as the root cause of the current medicines shortage …
Next generation Malaria drug shows promise
September 6, 2010Research and Development malaria
A Novartis-led collaboration has discovered a novel anti-malarial candidate that could become the first new treatment for the disease in …
Olivier Bohuon takes post at Pierre Fabre
September 6, 2010Sales and Marketing Pierre Fabre, appointment, sales and marketing
French pharma company Pierre Fabre has officially appointed Olivier Bohuon to take over from Jean-Pierre Garnier as chief executive. Olivier’s …
Sanofi’s Multaq in pole position for AF market
September 6, 2010Sales and Marketing Multaq, Sanofi-Aventis, atrial fibrilation
New European Society of Cardiology guidelines on treating atrial fibrillation (AF) include a recommendation for Sanofi-Aventis’ Multaq. The endorsement is …
Pradaxa, Xarelto and apixaban vie for attention
September 6, 2010Research and Development, Sales and Marketing Pradaxa, Xarelto, apixaban, atrial fibrilation
New data has intensified the competition between three rival would-be cardiology blockbusters. Boehringer Ingelheim’s Pradaxa (dabigatran) and Bayer’s Xarelto (rivaroxaban) …
Watchdog resignation forced ‘to appease pharma’
September 6, 2010Sales and Marketing Germany, IQWIG
The head of Germany’s medicines cost-effectiveness watchdog was forced to resign because he was a vocal critic of the pharma …
Huntsworth makes European strategy appointment
September 3, 2010Medical Communications Huntsworth, appointment, medical communications
UK communications company Huntsworth Health has appointed Annabelle Sandeman as European Director Strategic Development. She will report to chief executive …
Roche: ‘We will work to eliminate barriers to social media’
September 3, 2010Medical Communications Digital Pharma blog, Roche, social media
Last month Roche broke new ground for pharma by publishing its Social Media Principles (full details of which you can …
Roche set for jobs cuts from 2011
September 3, 2010Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, job cuts
Roche has confirmed it will take wide-ranging steps to reduce costs, following local reports the Swiss pharma firm was poised …
AZ’s Seroquel extends European licence
September 3, 2010Sales and Marketing AstraZeneca, Seroquel
AstraZeneca’s controversial anti-psychotic drug Seroquel has been given the green light in Europe as an add-on treatment for serious depressive …
Merck wins double approval in Europe
September 3, 2010Sales and Marketing Brinavess, Merck & Co, Syncrest, merck sharp and dohme
European regulators have given the green light for two of Merck & Co’s new drugs, licensing its anti-psychotic treatment Sycrest …
Industry supports Australia’s new price deal
September 3, 2010Sales and Marketing Australia, global pricing, price cuts
Australia’s pharmaceutical industry is urging the country’s legislators to pass a new medicines pricing bill that aims to save Aus$1.9 …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
